RxDoctor Payments Data

Bilal Louzati

Foot & Ankle Surgery · Washington, DCNPI 1528794013

Payments from drug & device makers

What this record shows

The money is spread across several categories — grants (55.7%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 23 manufacturers reported payments, led by Arthrex at 55.7% of the total. 2025 is the largest year on record at $13,397, more than ten times the $254 reported in 2022.

$17,962in general payments, 2019–2025

Across 64 payments — averaging $280.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Arthrex$10K
  • Smith+Nephew$2K
  • Medical Device Business Services, Inc.$1K
  • Paragon 28, Inc.$1K
  • Integra Lifesciences Corporation$741
  • Stryker$399
  • plus $2K from 17 others

What the payments were for

  • Grants$10,00056%
  • Travel & lodging$3,74521%
  • Food & beverage$4,21723%

General payments by program year

22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$17,962 in reported general payments places this provider in the 75th percentile of 23 foot & ankle surgery providers in District of Columbia.

See all foot & ankle surgery providers in District of Columbia

Other foot & ankle surgery in Washington

See the full list for District of Columbia

Where these figures come from

Is this you, or does something look wrong? →